Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain

Neurobiology of Aging

Volumn 35, Issue 8, 2014, Pages 1850-1854

  Condliffe, Daniel ^a,d   Wong, Andrew ^a   Troakes, Claire ^a   Proitsi, Petroula ^a   Patel, Yogen ^a   Chouliaras, Leonidas ^b   Fernandes, Cathy ^a   Cooper, Jonathan ^a   Lovestone, Simon ^a   Schalkwyk, Leonard ^a   Mill, Jonathan ^a,c   Lunnon, Katie ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 caC; 5 carboxylcytosine; 5 fC; 5 formylcytosine; 5 hmC; 5 hydroxymethylcytosine; 5 mC; 5 methylcytosine; Alzheimer's disease; Brain; DNA methylation; Epigenetics

Indexed keywords

5 CARBOXYLCYTOSINE; 5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; CYTOSINE; UNCLASSIFIED DRUG; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLAVERMECTINS; IVERMECTIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; ENTORHINAL CORTEX; EPIGENETICS; HUMAN; IMMUNOFLUORESCENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; ANALOGS AND DERIVATIVES; BRAIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM; METHYLATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CYTOSINE; EPIGENESIS, GENETIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IVERMECTIN; MALE; METHYLATION;

EID: 84899943291     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.002     Document Type: Article

References (29)

1. Bakulski K.M., Dolinoy D.C., Sartor M.A., Paulson H.L., Konen J.R., Lieberman A.P., Albin R.L., Hu H., Rozek L.S. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J.Alzheimer's Dis. 2012, 29:571-588.
2. Booth M.J., Branco M.R., Ficz G., Oxley D., Krueger F., Reik W., Balasubramanian S. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336:934-937.
3. Booth M.J., Ost T.W., Beraldi D., Bell N.M., Branco M.R., Reik W., Balasubramanian S. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nat. Protoc. 2013, 8:1841-1851.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991, 82:239-259.
5. Chouliaras L., Mastroeni D., Delvaux E., Grover A., Kenis G., Hof P.R., Steinbusch H.W., Coleman P.D., Rutten B.P., van den Hove D.L. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 2013, 34:2091-2099.
6. Davies M.N., Volta M., Pidsley R., Lunnon K., Dixit A., Lovestone S., Coarfa C., Harris R.A., Milosavljevic A., Troakes C., Al-Sarraj S., Dobson R., Schalkwyk L.C., Mill J. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012, 13:R43.
7. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
8. Globisch D., Munzel M., Muller M., Michalakis S., Wagner M., Koch S., Bruckl T., Biel M., Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PloS One 2010, 5:e15367.
9. Hashimoto H., Liu Y., Upadhyay A.K., Chang Y., Howerton S.B., Vertino P.M., Zhang X., Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40:4841-4849.
10. Inoue A., Shen L., Dai Q., He C., Zhang Y. Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res. 2011, 21:1670-1676.
11. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
12. Jin S.G., Kadam S., Pfeifer G.P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 2010, 38:e125.
13. Jin S.G., Wu X., Li A.X., Pfeifer G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res. 2011, 39:5015-5024.
14. Khare T., Pai S., Koncevicius K., Pal M., Kriukiene E., Liutkeviciute Z., Irimia M., Jia P., Ptak C., Xia M., Tice R., Tochigi M., Morera S., Nazarians A., Belsham D., Wong A.H., Blencowe B.J., Wang S.C., Kapranov P., Kustra R., Labrie V., Klimasauskas S., Petronis A. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat. Struct. Mol. Biol. 2012, 19:1037-1043.
15. Li W., Liu M. Distribution of 5-hydroxymethylcytosine in different human tissues. J.Nucleic Acids 2011, 2011:870726.
16. Lunnon K., Mill J. Epigenetic studies in Alzheimer's disease: current findings, caveats and considerations for future studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013, 162:789-799.
17. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
18. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PloS One 2009, 4:e6617.
19. Nestor C., Ruzov A., Meehan R., Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. BioTechniques 2010, 48:317-319.
20. Pidsley R., Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol. Psychiatry 2011, 69:146-156.
21. Raiber E.A., Beraldi D., Ficz G., Burgess H., Branco M.R., Murat P., Oxley D., Booth M.J., Reik W., Balasubramanian S. Genome-wide distribution of 5-formylcytosine in ES cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol. 2012, 13:R69.
22. Rao J.S., Keleshian V.L., Klein S., Rapoport S.I. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Translational Psychiatry 2012, 2:e132.
23. Song C.X., Szulwach K.E., Dai Q., Fu Y., Mao S.Q., Lin L., Street C., Li Y., Poidevin M., Wu H., Gao J., Liu P., Li L., Xu G.L., Jin P., He C. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013, 153:678-691.
24. Song C.X., Yi C., He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat. Biotechnol. 2012, 30:1107-1116.
25. Stroud H., Feng S., Morey Kinney S., Pradhan S., Jacobsen S.E. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011, 12:R54.
26. Szulwach K.E., Li X., Li Y., Song C.X., Wu H., Dai Q., Irier H., Upadhyay A.K., Gearing M., Levey A.I., Vasanthakumar A., Godley L.A., Chang Q., Cheng X., He C., Jin P. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 2011, 14:1607-1616.
27. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
28. Thies W., Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011, 7:208-244.
29. Vincent J.J., Huang Y., Chen P.Y., Feng S., Calvopina J.H., Nee K., Lee S.A., Le T., Yoon A.J., Faull K., Fan G., Rao A., Jacobsen S.E., Pellegrini M., Clark A.T. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 2013, 12:470-478.